Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2
- PMID: 6201587
- PMCID: PMC2187293
- DOI: 10.1084/jem.159.5.1473
Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2
Abstract
This report describes a Ts costimulator assay and its use to analyze cofactors required for the expression of suppressor T cell function. Activation of primed MLR-Ts (alloantigen-activated suppressor T cells suppressive of mixed leukocyte reaction) to suppressor T cell factor (TsF) production typically fails in the presence of glutaraldehyde-fixed rather than irradiated allogeneic stimulator cells. However, MLR-TsF production was restored by the addition of 48-h primary MLR supernates; MLR-derived Ts costimulator neither activated primed MLR-Ts in the absence of fixed allogeneic stimulators nor directly suppressed assay MLR. Lack of antigen specificity or genetic restriction and failure to activate unprimed MLR-Ts precursors suggested that Ts costimulator activity differed from previously described Ts inducer functions and was more closely aligned with the lymphocyte- or monocyte-derived interleukins (IL). Three findings distinguished Ts costimulator from IL-2. Depletion of IL-2 activity from MLR supernates by HT2 adsorption failed to affect Ts costimulator function. In addition, MLR supernates prepared in the presence of cyclosporin A contained no IL-2 but expressed Ts costimulator activity. Finally, gel chromatography demonstrated Ts costimulator in peaks of 21,000 and 43,000 mol wt that were largely distinct from the IL-2-containing fractions. Ts costimulator activity was also identified in phorbol myristate acetate (PMA)-induced EL4 supernates and was retained in those supernates after IL-2 depletion by HT2 adsorption. In preliminary functional characterization, MLR supernate-derived Ts costimulator triggered MLR-TsF production from irradiated MLR-Ts in the absence of proliferation. Thus a differentiative rather than proliferative stimulus required for primed MLR-Ts function appears to be provided by this Ts costimulator and has been provisionally termed Ts differentiative factor ( TsDF ). This initial characterization may thus identify one of a possibly distinctive family of interleukins required in the alloantigen-driven activation of suppressor T cells to effector function.
Similar articles
-
Suppressor T cell growth and differentiation: production of suppressor T cell differentiation factor by the murine thymoma BW5147.J Immunol. 1987 Jan 1;138(1):78-86. J Immunol. 1987. PMID: 2946782
-
Suppressor T cell growth and differentiation: evidence for induced receptors on suppressor T cells that bind a suppressor T cell differentiation factor.J Immunol. 1987 Jan 15;138(2):504-12. J Immunol. 1987. PMID: 3025299
-
Suppressive mechanisms in alloantigen-induced T cell responses.J Exp Med. 1983 Dec 1;158(6):1853-67. doi: 10.1084/jem.158.6.1853. J Exp Med. 1983. PMID: 6227676 Free PMC article.
-
The induction of autoreactive T lymphocytes by allogeneic effect factor (AEF): relevance to normal pathways of lymphocyte differentiation.Immunol Rev. 1980;51:3-34. doi: 10.1111/j.1600-065x.1980.tb00315.x. Immunol Rev. 1980. PMID: 6159301 Review. No abstract available.
-
I-J subregion and suppressor signals.Surv Immunol Res. 1982;1(1):67-75. doi: 10.1007/BF02918242. Surv Immunol Res. 1982. PMID: 6227066 Review. No abstract available.
Cited by
-
Mechanism of MHC class II restriction in the interaction between specific suppressor and responder T cells in a proliferative response: Ia interaction with a putative anti-self receptor, expressed on pre-activated responder cells.Immunology. 1990 Jul;70(3):372-8. Immunology. 1990. PMID: 2143172 Free PMC article.
-
Effect of murine interferon alpha/beta on tumour-induced suppressor function.Cancer Immunol Immunother. 1994 Dec;39(6):360-6. doi: 10.1007/BF01534422. Cancer Immunol Immunother. 1994. PMID: 8001023 Free PMC article.
-
Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.Jpn J Cancer Res. 1989 Feb;80(2):150-7. doi: 10.1111/j.1349-7006.1989.tb02283.x. Jpn J Cancer Res. 1989. PMID: 2498249 Free PMC article.
-
Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.Cancer Immunol Immunother. 1989;28(3):218-24. doi: 10.1007/BF00204992. Cancer Immunol Immunother. 1989. PMID: 2522349 Free PMC article.
-
Immune suppression genes.Clin Exp Immunol. 1989 Feb;75(2):167-77. Clin Exp Immunol. 1989. PMID: 2467772 Free PMC article. Review. No abstract available.